S.Biomedics Co., Ltd. (KOSDAQ:304360)
South Korea · Delayed Price · Currency is KRW 31,450
+1,650 (5.54%)
At close: Jun 12, 2026
S.Biomedics Market Cap
S.Biomedics has a market cap or net worth of 389.51 billion as of June 12, 2026. Its market cap has increased by 61.00% in one year.
Market Cap
389.51B
Enterprise Value
400.03B
Revenue
16.48B
Ranking
n/a
PE Ratio
n/a
Stock Price
31,450.00
Market Cap Chart
Since May 4, 2023, S.Biomedics's market cap has increased from 206.56B to 389.51B, an increase of 88.57%. That is a compound annual growth rate of 22.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 389.51B | -14.10% |
| Dec 30, 2025 | 453.47B | 123.16% |
| Dec 30, 2024 | 203.20B | 55.86% |
| Dec 28, 2023 | 130.38B | -36.88% |
| May 4, 2023 | 206.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inventage Lab | 582.21B |
| Curocell | 430.13B |
| IMBiologics | 393.05B |
| IntoCell | 356.02B |
| HansBiomed | 336.57B |
| Genome & Company | 259.75B |
| curacle co.,ltd. | 252.45B |
| Kanaph Therapeutics | 244.31B |